欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
ES/V/0233/001
药品名称
REVERSE
活性成分
atipamezole hydrochloride 5.0 mg/ml
剂型
Solution for injection
上市许可持有人
Fatro S.p.A
参考成员国 - 产品名称
Spain (ES)
REVERSE 5 MG/ML SOLUCIÓN INYECTABLE PARA PERROS Y GATOS
互认成员国 - 产品名称
Portugal (PT)
Italy (IT)
许可日期
2016/01/27
最近更新日期
2023/11/24
药物ATC编码
QV03AB90 atipamezole
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Generic - art 13.2 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Labelling
|
common_labelling_proposed_clean_day_90
Date of last change:2024/09/06
Final PL
|
common_pl_clean_day_90
Date of last change:2024/09/06
Final SPC
|
common_spc_day_90
Date of last change:2024/09/06
PubAR
|
PuAR_REVERSE
Date of last change:2024/09/06
Final Product Information
|
spc_labelling_pl_qrd_vers_9_proposed_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase